The National Clinical Care Commission Report to Congress: Leveraging Federal Policies and Programs to Prevent Diabetes in People With Prediabetes.
Journal
Diabetes care
ISSN: 1935-5548
Titre abrégé: Diabetes Care
Pays: United States
ID NLM: 7805975
Informations de publication
Date de publication:
01 02 2023
01 02 2023
Historique:
received:
29
03
2022
accepted:
03
11
2022
entrez:
26
1
2023
pubmed:
27
1
2023
medline:
31
1
2023
Statut:
ppublish
Résumé
Individuals with an elevated fasting glucose level, elevated glucose level after glucose challenge, or elevated hemoglobin A1c level below the diagnostic threshold for diabetes (collectively termed prediabetes) are at increased risk for type 2 diabetes. More than one-third of U.S. adults have prediabetes but fewer than one in five are aware of the diagnosis. Rigorous scientific research has demonstrated the efficacy of both intensive lifestyle interventions and metformin in delaying or preventing progression from prediabetes to type 2 diabetes. The National Clinical Care Commission (NCCC) was a federal advisory committee charged with evaluating and making recommendations to improve federal programs related to the prevention of diabetes and its complications. In this article, we describe the recommendations of an NCCC subcommittee that focused primarily on prevention of type 2 diabetes in people with prediabetes. These recommendations aim to improve current federal diabetes prevention activities by 1) increasing awareness of and diagnosis of prediabetes on a population basis; 2) increasing the availability of, referral to, and insurance coverage for the National Diabetes Prevention Program and the Medicare Diabetes Prevention Program; 3) facilitating Food and Drug Administration review and approval of metformin for diabetes prevention; and 4) supporting research to enhance the effectiveness of diabetes prevention. Cognizant of the burden of type 1 diabetes, the recommendations also highlight the importance of research to advance our understanding of the etiology of and opportunities for prevention of type 1 diabetes.
Identifiants
pubmed: 36701590
pii: 148317
doi: 10.2337/dc22-0620
pmc: PMC9887613
doi:
Substances chimiques
Metformin
9100L32L2N
Glucose
IY9XDZ35W2
Types de publication
Journal Article
Research Support, U.S. Gov't, P.H.S.
Research Support, N.I.H., Extramural
Review
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
e39-e50Subventions
Organisme : NIDDK NIH HHS
ID : P30 DK020572
Pays : United States
Informations de copyright
© 2023 by the American Diabetes Association.
Références
Diabetes Care. 2020 Jan;43(Suppl 1):S14-S31
pubmed: 31862745
Diabetes Care. 2020 Sep;43(9):2042-2049
pubmed: 32616617
Diabetes Care. 2003 Sep;26(9):2518-23
pubmed: 12941712
PLoS Med. 2016 Jul 26;13(7):e1002095
pubmed: 27459705
BMJ Open Diabetes Res Care. 2020 Apr;8(1):
pubmed: 32312721
Appl Health Econ Health Policy. 2020 Oct;18(5):713-726
pubmed: 32607728
Lancet. 2011 Jul 9;378(9786):147-55
pubmed: 21705064
Am J Prev Med. 2018 Aug;55(2):e39-e47
pubmed: 29934016
Lancet Diabetes Endocrinol. 2015 Nov;3(11):866-75
pubmed: 26377054
N Engl J Med. 2019 Aug 15;381(7):603-613
pubmed: 31180194
Diabetes Care. 2022 Oct 1;45(10):2396-2405
pubmed: 35724304
Curr Diab Rep. 2018 Oct 23;18(12):136
pubmed: 30353256
BMJ. 2020 Jul 15;370:m2297
pubmed: 32669282
Diabetologia. 2020 Aug;63(8):1530-1541
pubmed: 32382815
N Engl J Med. 2014 Aug 28;371(9):796-7
pubmed: 25162885
Diabetes Care. 2005 Apr;28(4):888-94
pubmed: 15793191
Prev Chronic Dis. 2019 Jun 27;16:E82
pubmed: 31255186
Health Aff (Millwood). 2017 Mar 1;36(3):417-424
pubmed: 28264942
Fed Regist. 2017 Nov 15;82(219):52976-3371
pubmed: 29231695
Diabetes Res Clin Pract. 2007 Dec;78(3):305-12
pubmed: 17601626
Perm J. 2018;22:17-050
pubmed: 29309270
Pediatr Diabetes. 2019 Mar;20(2):172-179
pubmed: 30556249
J Am Board Fam Med. 2019 Jul-Aug;32(4):505-512
pubmed: 31300570
Lancet. 2009 Nov 14;374(9702):1677-86
pubmed: 19878986
Diabetologia. 2017 Sep;60(9):1601-1611
pubmed: 28770322
Diabetes Care. 2003 Apr;26(4):977-80
pubmed: 12663559
Lancet Reg Health Eur. 2022 May 29;19:100420
pubmed: 35664052
JAMA Intern Med. 2017 Dec 1;177(12):1808-1817
pubmed: 29114778
Prev Chronic Dis. 2021 Mar 11;18:E22
pubmed: 33705304
Diabetes Care. 2022 Jan 1;45(Suppl 1):S17-S38
pubmed: 34964875
Diabetes Care. 2017 Dec;40(12):1668-1677
pubmed: 29021207
JAMA. 2002 May 15;287(19):2542-51
pubmed: 12020335
Fed Regist. 2015 Jul 14;80(134):41317-47
pubmed: 26173301
Diabetes Care. 2023 Feb 1;46(2):e14-e23
pubmed: 36701594
BMJ Open. 2015 Aug 19;5(8):e007316
pubmed: 26289448
JAMA. 2021 Aug 24;326(8):736-743
pubmed: 34427594
J Am Coll Cardiol. 2011 Jul 5;58(2):140-6
pubmed: 21718910
Diabetes Care. 2012 Apr;35(4):723-30
pubmed: 22442395
Am J Prev Med. 2020 Jul;59(1):79-87
pubmed: 32418801
N Engl J Med. 2001 May 3;344(18):1343-50
pubmed: 11333990
Diabetes Care. 2007 Mar;30(3):753-9
pubmed: 17327355
J Gen Intern Med. 2017 Nov;32(11):1172-1178
pubmed: 28730532
Ann Intern Med. 2021 Jan;174(1):25-32
pubmed: 33136426
Fed Regist. ;81(220):80170-562
pubmed: 27906531
Circulation. 2022 May 31;145(22):1632-1641
pubmed: 35603600
Diabetes Care. 2014 Feb;37(2):565-8
pubmed: 24271190
Health Aff (Millwood). 2022 Jul;41(7):971-979
pubmed: 35759735
Nat Med. 2021 Jan;27(1):49-57
pubmed: 33398163
Lancet. 2012 Jun 16;379(9833):2279-90
pubmed: 22683128
N Engl J Med. 2002 Feb 7;346(6):393-403
pubmed: 11832527
Int J Environ Res Public Health. 2017 Apr 26;14(5):
pubmed: 28445431
Arch Intern Med. 2011 Aug 8;171(15):1352-60
pubmed: 21824948
Clin Diabetes. 2018 Jan;36(1):59-66
pubmed: 29382980
Am J Prev Med. 2018 Oct;55(4):565-574
pubmed: 30126667
Br Med J (Clin Res Ed). 1983 Sep 24;287(6396):867-70
pubmed: 6412862
JAMA Netw Open. 2019 May 3;2(5):e193160
pubmed: 31074808
BMJ. 2015 Feb 19;350:h454
pubmed: 25697494
J Am Coll Cardiol. 2021 Aug 3;78(5):453-464
pubmed: 34015477
Diabetes Care. 2019 Apr;42(4):601-608
pubmed: 30877090
Diabetes Care. 2022 Oct 1;45(10):2189-2201
pubmed: 36150059